AMNEAL PHARMS NY FDA Approval ANDA 210052

ANDA 210052

AMNEAL PHARMS NY

FDA Drug Application

Application #210052

Application Sponsors

ANDA 210052AMNEAL PHARMS NY

Marketing Status

Prescription001

Application Products

001TABLET, EXTENDED RELEASE;ORAL0.1MG0CLONIDINE HYDROCHLORIDECLONIDINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2017-11-20STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB1

CDER Filings

Accessdata Error
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210052
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.